have described a series of irreversible inhibitors (I; R = n-Pr, i-Pr, n-Bu) of elastase. Encouraged by the success of Wong et al. (1978) in designing an irreversible inhibitor (II) that reacted much faster with urokinase than with plasmin, we have synthesized the compound (I; R= +H3N-[CH2]6) and examined its specificity as an inhibitor towards several trypsin-like proteinases. This kinetic study was achieved by monitoring the progress of inhibition with fluorogenic substrates derived from lysyl-or arginyl-7-amino-4-methylcoumarin (Lys-Amc, Arg-Amc).
Experimental Materials
Trasylol was purchased from Bayer U.K., Haywards Heath, West Sussex, U.K. Boc-ValLeu-Lys-Amc (Kato et al., 1980) and Z-Arg-Amc (Zimmerman et al., 1977) were purchased from the Peptide Research Foundation, Osaka, Japan. ZGly-Gly-Arg-Amc was purchased from Serva, Heidelberg, West Germany. N-t-Butyloxycarbonyl-1,6-diaminohexane hydrochloride was purchased from Fluorochem, Glossop, Derbyshire, Abbreviations used: Amc, 7-amino-4-methylcoumarin; Boc-, t-butyloxycarbonyl-; Z; benzyloxycarbonyl-.
U.K. 1, I'-Carbonyldi-imidazole was purchased from Aldrich Chemical Co., Gillingham, Dorset, U.K. AnalaR-grade chemicals (BDH Chemicals, Poole, Dorset, U.K.) were used for preparation of buffers. 7-Amino-4-methylcoumarin was synthesized as described by Zimmerman et al. (1977) . Urokinase was purchased from Calbiochem, Bishop's Stortford, Herts., U.K. The contents of each vial (approx. 2000 Ploug units) were dissolved in 50% (w/v) glycerol/50mm-sodium phosphate buffer, pH8.0, and stored at -1 5°C. The pig kidney-cell plasminogen activator was a gift from Dr. J. Bobbitt of Eli Lilly Research Laboratories, Indianapolis, IN, U.S.A. The enzyme was stabilized by the presence of albumin, which was not removed from the preparation for the present work. Glu-plasminogen was isolated from outdated human plasma by affinity chromatography on lysine-Sepharose in the presence of Trasylol (Deutsch & Mertz, 1970 Schroeder & Shaw (1968) .
Synthesis of J-(N-6-amino-n-hexy0carbamoyl-imidazole (I; R = +H3N-[CH2]6) N-t-Butyloxycarbonyl-1,6-diaminohexane hydrochloride (100mmol) was suspended in dry tetrahydrofuran (100 ml) containing N-methylmorpholine (100mmol). 1,1-Carbonyldi-imidazole (100mmol) was added in one portion, and the mixture was stirred overnight at room temperature. Solvent was removed under reduced pressure, and the residue was distributed between ethyl acetate and water. The organic layer was separated and dried (over MgSO4). Evaporation of the solvent yielded an oil, which was homogeneous by t.l.c. The i.r. spectrum showed strong bands at 3370 cm-1 (v -NH), 1750 cm-1 (v -C=O, carbamoyl) and 1700cm-1 (v -C=O, urethane). The oil was treated with a mixture of trifluoroacetic acid (25 ml) and dichloromethane (25 ml) at 0°C for 30min, after which analysis by t.l.c. revealed the absence of starting material. Solvent was removed under reduced pressure, and the oily residue was treated with ethereal HC1 and then triturated with ethanol/diethyl ether (1: 3, v/v), affording a white crystalline solid (yield 75%). The (c) Determination of operational molarity of enzyme solutions. The operational molarity of all enzymes was determined by spectrofluorimetric titration with 4-methylumbelliferyl p-guanidinobenzoate (Jameson et al., 1973) . The normal method of titration was used with plasmin, thrombin and the kidney-cell plasminogen activator, since there is turnover of titrant with these enzymes. The concentrated incubation method was used with the other enzymes, since turnover was negligible in the time required for acylation.
Analysis of kinetic data
Initial velocities were computed by the method of Elmore et al. (1963 (5) and (6) by substitution.
Results and discussion A typical set of results obtained by using the discontinuous assay is shown in Fig. 1 . The resistance of thrombin and Factor Xa to the inhibitor contrasts with the sensitivity of plasmin, urokinase and kidney-cell plasminogen activator. Fig. 2 is a typical example of the use of the continuous-assay technique, and shows the effect of inhibitor concentration on the rate of hydrolysis of a fluorogenic substrate by plasmin. The kinetic constants for the inhibition of urokinase, ,B-trypsin, kidney-cell plasminogen activator and plasmin by the inhibitor are given in Table 1 . It will be seen The inhibition studies were carried out at 37°C in 50mM-phosphate buffer, pH8.0. The concentrations of enzyme and inhibitor used in each study were as follows: A, Factor Xa, 4.5 pM, and inhibitor, 3.44mM; 0, thrombin, 3.6pM, and inhibitor, 9.00mM; Ol, plasmin, 1.4pM, and inhibitor, 0.72mM; A, urokinase, 1.76jiM, and inhibitor, 0.55mM; 0, that Ki values differ by a factor of less than 2-fold whereas the ki for urokinase and plasmin differ by an order of magnitude. Groutas et al., (1980) have postulated a 'suicide' mechanism for the inhibition of elastase by inhibitor (I; R = n-Pr, i-Pr or n-Bu) in which the imidazole N atom of His-57 abstracts a proton from the R-NH-CO-moiety of the inhibitor, causing the breakdown of (I) to the alkyl isocyanate. They cite as supporting evidence (a) the ready dissociation of compounds of type (I) into isocyanates and imidazole (Staab & Benz, 1961) and (b) the reaction of the hydroxy group of Ser-195 in serine proteinases with alkyl isothiocyanates (Brown & Wold, 1973a,b) . Since, however, aryl carbazates are able to acylate Ser-195 in trypsin and chymotrypsin directly (Smyth & Elmore, 1968) , and p-nitrophenyl esters of N-(co-aminoalkyl)carbamic acids acylate Ser-195 of trypsin (Scofield et al., 1977) , it is possible that the inhibition of trypsin-like enzymes by the inhibitor (I; R = +H3N-{CH2]6) described in the present paper operates by direct acylation.
